GLP-1 S
GLP-1 S is a selective GLP-1 receptor agonist peptide. Its sequence is about 94 percent...
GLP receptor agonist research peptides: GLP-1 S, GLP-2 TZ and GLP-3 RT from 10mg, 99%+ HPLC purity, identity confirmed, COA per lot. Research use only.
GLP-1 S is a selective GLP-1 receptor agonist peptide. Its sequence is about 94 percent...
GLP-2 TZ, ten vials in a protective case, 10mg or 30mg.
GLP-3 / Cagri, 10mg / 2mg to 12.5mg / 2.5mg from $95. A triple-receptor incretin compound...
GLP-3 RT, ten vials in a protective case, 5mg to 60mg.
This class groups the three house-designated incretin-receptor peptides. GLP-1 S is a GLP-1 receptor agonist peptide. GLP-2 TZ is a DPP-IV-resistant 33-amino-acid GLP-2 receptor agonist peptide. GLP-3 RT is a triple GLP-1, GIP and glucagon receptor agonist peptide. The names are house designations; the product pages describe each compound by receptor class, chain length and the analytical data on its certificate.
All three are sold in multiple vial sizes, from 10 mg upward, with the certificate of analysis for the current lot linked from each size. Purity is reported by HPLC and identity by mass confirmation per lot; the certificates for these lots are in the COA library alongside every other compound.
Regulatory note: approved pharmaceutical formulations exist for compounds in the incretin class. The research-grade peptides sold here are not those products. They are for in vitro research only, and nothing on this site describes use in a person or an animal.
Each product page links its monograph in the research library, which documents receptor class, structure and the analytical record without naming any pharmaceutical product.